Citibank, N.A., as Administrative AgentExtension of Maturity Date • July 28th, 2021 • Bristol Myers Squibb Co • Pharmaceutical preparations
AMENDMENT AND WAIVERFive Year Competitive Advance and Revolving Credit Facility Agreement • July 28th, 2021 • Bristol Myers Squibb Co • Pharmaceutical preparations • New York
AMENDMENT AND WAIVER (this “Amendment and Waiver”), dated as of June 22, 2021, by and among BRISTOL-MYERS SQUIBB COMPANY, a Delaware corporation (the “Company”), the Lenders (as defined below) party hereto and the Administrative Agent (as defined below), which amends that certain FIVE YEAR COMPETITIVE ADVANCE AND REVOLVING CREDIT FACILITY AGREEMENT (as amended, supplemented or otherwise modified from time to time prior to the effectiveness of this Amendment and Waiver, the “Existing Credit Agreement” and as modified by this Amendment and Waiver, the “Credit Agreement”) dated as of September 29, 2011, among the Company, the BORROWING SUBSIDIARIES (as defined in the Credit Agreement) from time to time party thereto, the lenders from time to time party thereto (the “Lenders”), certain Agents, JPMORGAN CHASE BANK, N.A., as Administrative Agent (in such capacity, “JPMCB”), and CITIBANK, N.A., as Administrative Agent (in such capacity, “CBNA”; JPMCB and CBNA are referred to herein individual
AMENDMENTFive Year Competitive Advance and Revolving Credit Facility Agreement • July 28th, 2021 • Bristol Myers Squibb Co • Pharmaceutical preparations • New York
AMENDMENT (this “Amendment”), dated as of June 22, 2021, by and among BRISTOL-MYERS SQUIBB COMPANY, a Delaware corporation (the “Company”), the Lenders (as defined below) party hereto and the Administrative Agent (as defined below), which amends that certain FIVE YEAR COMPETITIVE ADVANCE AND REVOLVING CREDIT FACILITY AGREEMENT (as amended, supplemented or otherwise modified from time to time prior to the effectiveness of this Amendment, the “Existing Credit Agreement” and as modified by this Amendment, the “Credit Agreement”) dated as of July 30, 2012, among the Company, the BORROWING SUBSIDIARIES (as defined in the Credit Agreement) from time to time party thereto, the lenders from time to time party thereto (the “Lenders”), certain Agents, JPMORGAN CHASE BANK, N.A., as Administrative Agent (in such capacity, “JPMCB”), and CITIBANK, N.A., as Administrative Agent (in such capacity, “CBNA”; JPMCB and CBNA are referred to herein individually as an “Administrative Agent” and collectively
Citibank, N.A., as Administrative AgentCredit Agreement • July 28th, 2021 • Bristol Myers Squibb Co • Pharmaceutical preparations
